Recording: Can PSMA PET/CT spare extended pelvic lymph node dissection in high-risk prostate cancer?
In this recording, we will discuss the growing role of molecular imaging, particularly PSMA PET/CT, in the preoperative staging of patients with high-risk prostate cancer undergoing radical prostatectomy.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | Not approved |
| Duration | Approx. 60 minutes |
The main aims are to scrutinise the benefits, pitfalls, and challenges of this novel staging pathway, and to examine the current evidence and guidelines on the indications of pelvic lymph node dissection at the time of radical prostatectomy. The ongoing trials regarding this topic will also be highlighted.
Speakers:
- G. Gandaglia, Milan (IT)
- I. Burger, Baden (CH)
- J. Stranne, Göteborg (SE)
- G. Giannarini, Udine (IT)
This recording is brought to you in collaboration the EAU Section of Oncological Urology (ESOU) and Guidelines Office.